April 15, 2024 11:10 AM EDT
News Briefing

Mus­tang Bio to lay off work­ers; MaaT's new da­ta for mi­cro­bio­me ther­a­py

ENDPOINTS

Mus­tang Bio ax­es 81% of staffers: The CAR-T cell ther­a­py com­pa­ny plans to im­ple­ment a work­force re­duc­tion through­out April to pre­serve cash in the sec­ond …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times